Mackenzie Financial »

Theravance Biopharma shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $705k 37k 18.87
2020-03-31 $784k 34k 23.12

More positions owned by Mackenzie Financial

Rbc Cad (RY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Toronto Dominion Bk Ont Com New (TD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Shopify Cl A Sub Vtg Shs (SHOP)
Amazon (AMZN)
Agnico (AEM)
Bank Of Montreal Cadcom (BMO)
Canadian Pacific Kansas City (CP)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Canadian Natural Resources (CNQ)
Manulife Finl Corp (MFC)

View all positions for Mackenzie Financial

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
Newtyn Management
BlackRock
Irenic Capital Management
Vanguard Group
Park West Asset Management
D. E. Shaw & Co
Acadian Asset Management
State Street Corporation
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Dimensional Fund Advisors
Oasis Management
UBS Group

View all funds holding Theravance Biopharma